Skip to main content
Top
Published in: BMC Infectious Diseases 1/2014

Open Access 01-12-2014 | Research article

Proliferative capacity and cytokine production by cells of HIV-infected and uninfected adults with different helminth infection phenotypes in South Africa

Authors: Zilungile L Mkhize-Kwitshana, Musawenkosi LH Mabaso, Gerhard Walzl

Published in: BMC Infectious Diseases | Issue 1/2014

Login to get access

Abstract

Background

It has been suggested that the proliferative capacity of cells from individuals with HIV or both HIV and helminth infections is attenuated and cytokine production is dysregulated. This study describes peripheral blood mononuclear cell proliferation capacity and cytokine profile from individuals with HIV or both HIV and helminth infections in South Africa.

Methods

Forty HIV-infected and 22 HIV-uninfected participants were randomly selected and stratified into different helminth infection phenotypes by egg excretion and Ascaris lumbricoides specific –immunoglobulin-E (IgE) levels. Five day cell cultures of participants, unstimulated or stimulated with Phytohaemaglutinnin, Streptokinase, HIV-1 p24 and Ascaris lumbricoides worm antigens were stained with monoclonal antibody-fluorochrome conjugates (Ki67-FITC and CTLA-APC-4). Percentage expression of Ki67 and CTLA-4 was measured to determine cell proliferation and regulation, respectively. Culture supernatants were analysed for the expression of 13 cytokines using the Bioplex (BioRad) system. Kruskal Wallis was used to test for differences in variables between helminth infected subgroups who were either having eggs in stool and high IgE (egg+IgEhi); or eggs in stool and low IgE (egg+IgElo); or no eggs in stool and high IgE (egg-IgEhi) and those without helminth infection (egg-IgElo).

Results

Individuals excreting eggs in stool with high serum IgE (egg+IgEhi phenotype) had potent mitogen responses but consistently produced low, but statistically non-significant antigen–specific (HIV-1 p24 (p = 0.41) and Ascaris (p = 0.19) and recall antigen (Streptokinase; p = 0.31) Ki67 responses. The group also had reduced type 1 cytokines. Individuals excreting eggs in stool with low serum IgE( egg+IgElo phenotype) had a more favourable antiviral profile, characterized by higher IFNγ, IL-2, lower IL-4 and higher IL-10 production.

Conclusion

The findings suggest that dual HIV/helminth infection with egg excretion and/or high Ascaris IgE phenotye may be linked with poor proliferative capacity and deleterious cytokine profile with regards to HIV control.
Appendix
Available only for authorised users
Literature
1.
go back to reference Borkow G, Bentwich Z: Chronic immune activation associated with chronic helminthic and human immunodeficiency virus infections: role of hyporesponsiveness and anergy. Clin Microbiol Rev. 2004, 17 (4): 1012-1030. 10.1128/CMR.17.4.1012-1030.2004.CrossRefPubMedPubMedCentral Borkow G, Bentwich Z: Chronic immune activation associated with chronic helminthic and human immunodeficiency virus infections: role of hyporesponsiveness and anergy. Clin Microbiol Rev. 2004, 17 (4): 1012-1030. 10.1128/CMR.17.4.1012-1030.2004.CrossRefPubMedPubMedCentral
2.
go back to reference Hotez PJ, Mistry N, Rubinstein J, Sachs JD: Integrating neglected tropical diseases into AIDS, tuberculosis, and malaria control. N Engl J Med. 2011, 364: 2086-2089. 10.1056/NEJMp1014637.CrossRefPubMed Hotez PJ, Mistry N, Rubinstein J, Sachs JD: Integrating neglected tropical diseases into AIDS, tuberculosis, and malaria control. N Engl J Med. 2011, 364: 2086-2089. 10.1056/NEJMp1014637.CrossRefPubMed
3.
go back to reference Lawn SD, Butera S, Folks TM: The contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type1 infection. Clin Microbiol Rev. 2001, 14 (4): 753-777. 10.1128/CMR.14.4.753-777.2001.CrossRefPubMedPubMedCentral Lawn SD, Butera S, Folks TM: The contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type1 infection. Clin Microbiol Rev. 2001, 14 (4): 753-777. 10.1128/CMR.14.4.753-777.2001.CrossRefPubMedPubMedCentral
4.
go back to reference Day CL, Kiepiela P, Leslie AJ, van der Stok M, Nair K, Ismael I, Honeyborne I, Crawford H, Coovadia HM, Goulder PJR, Walker BD, Klenerman P: Proliferative capacity of epitope-specific CD8 T-cell responses is inversely related to viral load in chronic human immunodeficiency virus type 1 infection. J Virol. 2007, 81 (1): 434-438. 10.1128/JVI.01754-06.CrossRefPubMed Day CL, Kiepiela P, Leslie AJ, van der Stok M, Nair K, Ismael I, Honeyborne I, Crawford H, Coovadia HM, Goulder PJR, Walker BD, Klenerman P: Proliferative capacity of epitope-specific CD8 T-cell responses is inversely related to viral load in chronic human immunodeficiency virus type 1 infection. J Virol. 2007, 81 (1): 434-438. 10.1128/JVI.01754-06.CrossRefPubMed
5.
go back to reference Porto AF, Santos SB, Muniz AL, Basilio V, Rodrigues W, Neva FA, Dutra WO, Gollob KJ, Jacobson S, Carvalho EM: Helminthic infection down-regulates type 1 immune responses in human T cell lymphotropic virus type 1 (HTLV-1) carriers and is more prevalent in HTLV-1 carriers than in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis. J Infect Dis. 2005, 191 (4): 612-618. 10.1086/427560.CrossRefPubMed Porto AF, Santos SB, Muniz AL, Basilio V, Rodrigues W, Neva FA, Dutra WO, Gollob KJ, Jacobson S, Carvalho EM: Helminthic infection down-regulates type 1 immune responses in human T cell lymphotropic virus type 1 (HTLV-1) carriers and is more prevalent in HTLV-1 carriers than in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis. J Infect Dis. 2005, 191 (4): 612-618. 10.1086/427560.CrossRefPubMed
6.
go back to reference Clerici M, Shearer GM: The Th1 -Th2 hypothesis of HIV infection: new insights. Immunol Today. 1994, 15 (12): 575-581. 10.1016/0167-5699(94)90220-8.CrossRefPubMed Clerici M, Shearer GM: The Th1 -Th2 hypothesis of HIV infection: new insights. Immunol Today. 1994, 15 (12): 575-581. 10.1016/0167-5699(94)90220-8.CrossRefPubMed
7.
go back to reference Modjarrad K: HIV and helminths: time for a new direction. Lancet Infect Dis. 2013, 13 (10): 835-10.1016/S1473-3099(13)70239-1.CrossRefPubMed Modjarrad K: HIV and helminths: time for a new direction. Lancet Infect Dis. 2013, 13 (10): 835-10.1016/S1473-3099(13)70239-1.CrossRefPubMed
8.
go back to reference Soares A, Govender A, Hughes J, Mavakla W, deKock M, Barnard C, Pienaar B, Janse van Rensberg E, Jacobs G, Khomba G, Stone L, Abel B, Scriba TJ, Hanekom WA: Novel application of Ki67 to quantify antigen-specific in vitro lymphoproliferation. J Immunol Methods. 2010, 362 (1–2): 43-50. doi:10.1016/j.jim.2010.08.007CrossRefPubMedPubMedCentral Soares A, Govender A, Hughes J, Mavakla W, deKock M, Barnard C, Pienaar B, Janse van Rensberg E, Jacobs G, Khomba G, Stone L, Abel B, Scriba TJ, Hanekom WA: Novel application of Ki67 to quantify antigen-specific in vitro lymphoproliferation. J Immunol Methods. 2010, 362 (1–2): 43-50. doi:10.1016/j.jim.2010.08.007CrossRefPubMedPubMedCentral
9.
go back to reference Sachsenberg N, Perelson AS, Yerly S, Schockmel GA, Leduc D, Hirschel B, Perrin L: Turnover of CD4+ and CD8+ T lymphocytes in HIV-1 infection as measured by Ki-67 antigen. J Exp Med. 1998, 187: 1295-1303. 10.1084/jem.187.8.1295.CrossRefPubMedPubMedCentral Sachsenberg N, Perelson AS, Yerly S, Schockmel GA, Leduc D, Hirschel B, Perrin L: Turnover of CD4+ and CD8+ T lymphocytes in HIV-1 infection as measured by Ki-67 antigen. J Exp Med. 1998, 187: 1295-1303. 10.1084/jem.187.8.1295.CrossRefPubMedPubMedCentral
10.
11.
go back to reference Brunner MC, Chambers CA, Chang FK, Hanke J, Winoto A, Allison JP: CTLA-4 mediated inhibition of early events of T cell proliferation. J Immunol. 1999, 15: 5813-5820. Brunner MC, Chambers CA, Chang FK, Hanke J, Winoto A, Allison JP: CTLA-4 mediated inhibition of early events of T cell proliferation. J Immunol. 1999, 15: 5813-5820.
12.
go back to reference Adams VJ, Markus MB, Kwitshana ZL, Dhansay MA, van der Merwe L, Walzl G, Fincham JE: Recall of intestinal helminthiasis by HIV-infected South Africans and avoidance of possible misinterpretation of egg excretion in helminth/HIV co-infection analyses. BMC Infect Dis. 2006, 6 (88): 1-8. Adams VJ, Markus MB, Kwitshana ZL, Dhansay MA, van der Merwe L, Walzl G, Fincham JE: Recall of intestinal helminthiasis by HIV-infected South Africans and avoidance of possible misinterpretation of egg excretion in helminth/HIV co-infection analyses. BMC Infect Dis. 2006, 6 (88): 1-8.
13.
go back to reference World Health Organization: World Health Assembly Resolution WHA54. 19: Schistosomiasis and Soil-transmitted Helminth Infections. 2001, Geneva: World Health Organization World Health Organization: World Health Assembly Resolution WHA54. 19: Schistosomiasis and Soil-transmitted Helminth Infections. 2001, Geneva: World Health Organization
14.
go back to reference Mkhize-Kwitshana ZL, Taylor M, Pieter Jooste P, Mabaso MHL, Walzl G: The influence of different helminth infection phenotypes on immune responses against HIV in co-infected adults in South Africa. BMC Infect Dis. 2011, 11: 273-10.1186/1471-2334-11-273.CrossRefPubMedPubMedCentral Mkhize-Kwitshana ZL, Taylor M, Pieter Jooste P, Mabaso MHL, Walzl G: The influence of different helminth infection phenotypes on immune responses against HIV in co-infected adults in South Africa. BMC Infect Dis. 2011, 11: 273-10.1186/1471-2334-11-273.CrossRefPubMedPubMedCentral
15.
go back to reference Ritchie LS: Formol ether concentration. Bulletin of the United States Army Medical Department. 1948, 8: 326- Ritchie LS: Formol ether concentration. Bulletin of the United States Army Medical Department. 1948, 8: 326-
16.
go back to reference Peters PA, El AM, Warren KS, Mahmoud AA: Quick Kato smear for field quantification of Schistosoma mansoni eggs. AmJTrop Med Hyg. 1980, 29: 217-219. Peters PA, El AM, Warren KS, Mahmoud AA: Quick Kato smear for field quantification of Schistosoma mansoni eggs. AmJTrop Med Hyg. 1980, 29: 217-219.
17.
go back to reference Maizels RM, Yazdanbakhsh M, Allen JE: Immune regulation by helminth parasites: cellular and molecular mechanisms. Nat Rev Immunol. 2003, 3: 733-744. 10.1038/nri1183.CrossRefPubMed Maizels RM, Yazdanbakhsh M, Allen JE: Immune regulation by helminth parasites: cellular and molecular mechanisms. Nat Rev Immunol. 2003, 3: 733-744. 10.1038/nri1183.CrossRefPubMed
18.
go back to reference Leng Q, Borkow G, Weisman Z, Stein M, Kalinkovich A, Bentwich Z: Immune activation correlates better than HIV plasma viral load with CD4 T cell decline during HIV infection. J Acquir Immune Defic Syndr. 2001, 27: 389-397. 10.1097/00126334-200108010-00010.CrossRefPubMed Leng Q, Borkow G, Weisman Z, Stein M, Kalinkovich A, Bentwich Z: Immune activation correlates better than HIV plasma viral load with CD4 T cell decline during HIV infection. J Acquir Immune Defic Syndr. 2001, 27: 389-397. 10.1097/00126334-200108010-00010.CrossRefPubMed
20.
go back to reference Grogan JL, Kremsner PG, Deelder AM, Yazdanbakhsh M: Antigen-specific proliferation and interferon-g and interleukin-5 production are down-regulated during Schistosoma haematobium infection. J Infect Dis. 1998, 177: 1433-7. 10.1086/517832.CrossRefPubMed Grogan JL, Kremsner PG, Deelder AM, Yazdanbakhsh M: Antigen-specific proliferation and interferon-g and interleukin-5 production are down-regulated during Schistosoma haematobium infection. J Infect Dis. 1998, 177: 1433-7. 10.1086/517832.CrossRefPubMed
21.
go back to reference Kalinkovich A, Weisman Z, Greenberg Z, Nahmias J, Eitan S, Stein M, Bentwich Z: Decreased CD4 and increased CD8 counts with T cell activation is associated with chronic helminth infection. Clin Exp Immunol. 1998, 114 (3): 414-421. 10.1046/j.1365-2249.1998.00736.x.CrossRefPubMedPubMedCentral Kalinkovich A, Weisman Z, Greenberg Z, Nahmias J, Eitan S, Stein M, Bentwich Z: Decreased CD4 and increased CD8 counts with T cell activation is associated with chronic helminth infection. Clin Exp Immunol. 1998, 114 (3): 414-421. 10.1046/j.1365-2249.1998.00736.x.CrossRefPubMedPubMedCentral
22.
go back to reference Subramanyam M, Gutheil WG, Bachovchin WW, Huber BT: Mechanism of HIV-1 Tat induced inhibition of antigen-specific T cell responsiveness. J Immunol. 1993, 150 (6): 2544-2553.PubMed Subramanyam M, Gutheil WG, Bachovchin WW, Huber BT: Mechanism of HIV-1 Tat induced inhibition of antigen-specific T cell responsiveness. J Immunol. 1993, 150 (6): 2544-2553.PubMed
23.
go back to reference Secor WE, Shah A, Mwinzi PMN: Increased density of human immunodeficiency virus type 1 coreceptors CCR5 and CXCR4 on the surfaces of CD4+ T cells and monocytes of patients with Schistosoma mansoni infection. Infect Immun. 2003, 71 (11): 6668-6671. 10.1128/IAI.71.11.6668-6671.2003.CrossRefPubMedPubMedCentral Secor WE, Shah A, Mwinzi PMN: Increased density of human immunodeficiency virus type 1 coreceptors CCR5 and CXCR4 on the surfaces of CD4+ T cells and monocytes of patients with Schistosoma mansoni infection. Infect Immun. 2003, 71 (11): 6668-6671. 10.1128/IAI.71.11.6668-6671.2003.CrossRefPubMedPubMedCentral
24.
go back to reference Janeway CA, Travers P, Walport M, Shlomchik M: T-Cell Mediated Immunity. Immunobiology-The immune system in health and Disease. Edited by: Schanck D, Austin P, Lawrence E, Gibbs S. 2001, USA: Garland Publishing. Taylor and Francis group, 295-340. 5 Janeway CA, Travers P, Walport M, Shlomchik M: T-Cell Mediated Immunity. Immunobiology-The immune system in health and Disease. Edited by: Schanck D, Austin P, Lawrence E, Gibbs S. 2001, USA: Garland Publishing. Taylor and Francis group, 295-340. 5
25.
go back to reference Blish CA, Laura Sangaré LBR, Richardson BA, John-Stewart G, Walson JL: Changes in plasma cytokines following treatment of Ascaris lumbricoides in HIV-1 infected individuals. J Infect Dis. 2010, 201 (12): 1816-1821. 10.1086/652784. doi:10.1086/652784CrossRefPubMedPubMedCentral Blish CA, Laura Sangaré LBR, Richardson BA, John-Stewart G, Walson JL: Changes in plasma cytokines following treatment of Ascaris lumbricoides in HIV-1 infected individuals. J Infect Dis. 2010, 201 (12): 1816-1821. 10.1086/652784. doi:10.1086/652784CrossRefPubMedPubMedCentral
26.
go back to reference Sousa A, Chaves A, Loureiro A, Victorino R: Comparison of the frequency of interleukin2-, interferon –γ-, and IL-4-producing T cells in 2 diseases, human immunodeficiency virus types 1 and 2, with distinct clinical outcomes. J Infect Dis. 2001, 184 (5): 552-559. 10.1086/322804.CrossRefPubMed Sousa A, Chaves A, Loureiro A, Victorino R: Comparison of the frequency of interleukin2-, interferon –γ-, and IL-4-producing T cells in 2 diseases, human immunodeficiency virus types 1 and 2, with distinct clinical outcomes. J Infect Dis. 2001, 184 (5): 552-559. 10.1086/322804.CrossRefPubMed
27.
go back to reference van Riet E, Hartgers FC, Yazdanbakhsh M: Chronic helminth infections induce immunomodulation: consequences and mechanisms. Immunobiology. 2007, 212: 475-490. 10.1016/j.imbio.2007.03.009.CrossRefPubMed van Riet E, Hartgers FC, Yazdanbakhsh M: Chronic helminth infections induce immunomodulation: consequences and mechanisms. Immunobiology. 2007, 212: 475-490. 10.1016/j.imbio.2007.03.009.CrossRefPubMed
28.
go back to reference Maizels RM, Balic A, Gomez-Escobar N, Nair M, Taylor MD, Allen JE: Helminth parasites- masters of regulation. Immunol Rev. 2004, 201: 89-116. 10.1111/j.0105-2896.2004.00191.x.CrossRefPubMed Maizels RM, Balic A, Gomez-Escobar N, Nair M, Taylor MD, Allen JE: Helminth parasites- masters of regulation. Immunol Rev. 2004, 201: 89-116. 10.1111/j.0105-2896.2004.00191.x.CrossRefPubMed
29.
go back to reference Kocaoemer A, Kerns S, Kluter H, Bieback K: Human AB serum and thrombin-activated platelet –rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cells. 2007, 25 (5): 1279-1278. 10.1634/stemcells.2006-0747.CrossRef Kocaoemer A, Kerns S, Kluter H, Bieback K: Human AB serum and thrombin-activated platelet –rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cells. 2007, 25 (5): 1279-1278. 10.1634/stemcells.2006-0747.CrossRef
31.
go back to reference Godoy-Ramirez K, Franck K, Mahdavifar S, Andersson L, Gaines H: Optimum culture conditions for specific and nonspecific activation of whole blood and PBMC for intracellular cytokine assessment by flow cytometry. J Immunol Methods. 2004, 292: 1-15. 10.1016/j.jim.2004.04.028.CrossRefPubMed Godoy-Ramirez K, Franck K, Mahdavifar S, Andersson L, Gaines H: Optimum culture conditions for specific and nonspecific activation of whole blood and PBMC for intracellular cytokine assessment by flow cytometry. J Immunol Methods. 2004, 292: 1-15. 10.1016/j.jim.2004.04.028.CrossRefPubMed
32.
go back to reference Porichis F, Vlata Z, Hatzidakis G: HIV-1 gp120/V3-derived epitopes promote activation-induced cell death to superantigen–stimulated CD4+/CD45RO+ T cells. Immunol Lett. 2007, 108: 97-102. 10.1016/j.imlet.2006.11.002.CrossRefPubMed Porichis F, Vlata Z, Hatzidakis G: HIV-1 gp120/V3-derived epitopes promote activation-induced cell death to superantigen–stimulated CD4+/CD45RO+ T cells. Immunol Lett. 2007, 108: 97-102. 10.1016/j.imlet.2006.11.002.CrossRefPubMed
Metadata
Title
Proliferative capacity and cytokine production by cells of HIV-infected and uninfected adults with different helminth infection phenotypes in South Africa
Authors
Zilungile L Mkhize-Kwitshana
Musawenkosi LH Mabaso
Gerhard Walzl
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2014
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-14-499

Other articles of this Issue 1/2014

BMC Infectious Diseases 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.